Status:
NOT_YET_RECRUITING
Applicability of 3T Shoulder MRI in Detection of Labral Pathology
Lead Sponsor:
Henry Ford Health System
Conditions:
Labral Tear, Glenoid
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this observational study is to compare image quality between 3 Tesla magnet (3T) non-contrast MRI to the current standard of MR arthrogram (1.5T magnet) in detecting shoulder labral and...
Detailed Description
The specific aim of this investigation is to determine the accuracy and reliability of 3T MRI in the detection of shoulder labral and cartilage pathology as compared to the current standard of MR arth...
Eligibility Criteria
Inclusion
- Indicated for likely labral surgery
- Chronic, degenerative labral and/or cartilage pathology
- Ability to read and understand English
- Age ≥ 18 years
- Age ≤ 65 years
Exclusion
- Patient does not complete both the MR arthrogram and 3T non-contrast MRI
- Unexpected trauma in between the MR arthrogram and 3T non-contrast MRI
- Age \< 18 years
- Age \> 65 years
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT06043791
Start Date
September 1 2025
End Date
September 1 2026
Last Update
February 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health
Royal Oak, Michigan, United States, 48067